In this study, targeting Pdia4 seemed to have some advantage over the using antioxidant compounds and enzymes because Pdia4 deficiency eliminated the possibility of diabetes development by lowering ROS production, different from elimination of ROS by antioxidants, in which the cells continue to produce ROS through the ROS‐generating machinery. Here, PDIA4 is linked to diabetes mellitus.